Olanzapine/fluoxetine (trade name Symbyax, created by Eli Lilly and Company) is a fixed-dose combination medication containing olanzapine (Zyprexa), an atypical antipsychotic, and fluoxetine (Prozac), a selective serotonin reuptake inhibitor (SSRI).
Olanzapine/fluoxetine (trade name Symbyax, created by Eli Lilly and Company) is a single medication containing olanzapine (Zyprexa), an atypical antipsychotic, and fluoxetine (Prozac), a type of antidepressant.